Clinical Trials Directory

Trials / Sponsors / Biomea Fusion Inc.

Biomea Fusion Inc.

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targe
Type 2 Diabetes
Phase 22026-04-01
RecruitingPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 22026-03-27
Active Not RecruitingStudy of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants
Obesity
Phase 12025-10-23
CompletedFood Effect Study in Healthy Volunteers
Healthy Volunteer
Phase 12025-09-11
TerminatedPhase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
Phase 22023-12-28
Active Not RecruitingA Phase 1 Study of BMF-500 in Adults With Acute Leukemia
Acute Myeloid Leukemia
Phase 12023-07-26
TerminatedStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancr
Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer
Phase 12023-01-12
CompletedStudy of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)
Type 2 Diabetes Mellitus
Phase 1 / Phase 22022-08-17
TerminatedStudy of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutatio
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia
Phase 12022-01-24